614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study

Journal for ImmunoTherapy of Cancer(2023)

引用 0|浏览5
暂无评分
关键词
advanced solid tumors,antibody,solid tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要